Real-world data (RWD) overcomes the COVID-19 restrictions placed on entering hospitals

  • The digital options of real-world data (RWD) mean that you can still access the right patient population with the right study design
  • RWD is on an adoption curve and being increasing utilised to help pharma companies accelerate medical product development and provide new therapies to patients more efficiently in a very cost-efficient manner
  • RWD increases patient diversity in clinical trials, expands indications of already approved drugs, provides an external comparator arm in place of placebo and can help pharmaceutical companies make informed decision

Click here to learn more

About SVMPharma

SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.

For more information, please visit and contact us at

ref: JUL2020LN001

Posted in Blogs.